Cambridge, UK 07 February 2023– EVONETIX LTD (‘Evonetix’), the synthetic biology company bringing semiconductor technology to DNA synthesis, today announced it has completed a USD $24 million financing round, extending its total series B funding to over Read More
ieso raises $53m to address global mental health crisis with digital therapeutics US investor Morningside leads Series B financing to develop clinical software treatments for US market Financing led by Morningside, alongside new investors including Read More
This will close in 25 seconds
